We are live on ! Find out more
PILL icon

Direxion Daily Pharmaceutical & Medical Bull 3X ETF

5 hedge funds and large institutions have $962K invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more capital invested

Capital invested by funds: $475K → $962K (+$487K)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

25% more funds holding

Funds holding: 45 (+1)

2.62% more ownership

Funds ownership: 3.72%6.34% (+2.6%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
1
Jane Street
New York
$393K +$361K +47,966 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$321K +$21.8K +2,896 +8%
TRCT
3
Tower Research Capital (TRC)
New York
$239K -$18.3K -2,438 -8%
AA
4
AlphaMark Advisors
Kentucky
$8K
Morgan Stanley
5
Morgan Stanley
New York
$672 +$610 +81 New
UBS Group
6
UBS Group
Switzerland
-$46.9K -7,533 Closed

PILL Hedge Fund Activity: Q3 2024 in Review

5 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q3 2024, worth a combined $962K — up 103% from $475K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PILL positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $361K. The largest seller was UBS Group, exiting entirely with an estimated $46.9K sold.

  • 5 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q3 2024, up from 4 in Q2 2024.
  • Funds reported $962K of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q3 2024, up 103% quarter-over-quarter.
  • 2 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q3 2024 and 1 closed out, a net change of +1 holder.
  • The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q3 2024 was Jane Street, an estimated $361K added.
  • The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q3 2024 was UBS Group, an estimated $46.9K sold.

Based on aggregated 13F filings for Q3 2024.